U062 Advances in Microneedling Techniques Around the World
DESCRIPTION
The session aims to present updated, evidence-based practices and clinical pearls with a global perspective, using microneedling and other needling procedures in a safe and effective way to manage various common dermatoses. Conditions to be reviewed may include scars of various etiologies, striae distensae, pigmentary dermatoses and rhytides. The use of microneedling to facilitate transdermal drug delivery will additionally be reviewed. Microneedling and radiofrequency microneedling will be compared and discussed. Topics to be presented will include assessment approaches, supporting recent literature, clinical pearls and experiences, and discussion of adverse effects and management options.
LEARNING OBJECTIVES
Demonstrate the safe and effective use of microneedling in patients with various common dermatoses as performed in real-world clinical practice
Evaluate evidence-based practices using microneedling (vs. radiofrequency microneedling) for scars, striae and rhytides based on clinical experience and research
Formulate approaches and treatment plans that optimizes outcomes and minimize adverse effects, when targeting aesthetic and medical skin needs of patients using microneedling across the skin spectrum
SCHEDULE
8:00 AM
Introductions and Welcome
Monica Ka Yi Li, MD, FAAD, Tina S. Alster, MD, FAAD
8:05 AM
Practical use of microneedling for transdermal drug delivery: Insights from Korea
Boncheol Goo
8:18 AM
Microneedling and rejuvenation: Pearls from Thailand
Rungsima Wanitphakdeedecha, MD, IFAAD
8:31 AM
Use of Microneedling in Skin of Color: Treating hyperpigmented and hypertrophic scars
Robyn D. Siperstein, MD, FAAD
8:43 AM
Panel discussion and Q&A
DIRECTOR
Monica Ka Yi Li, MD, FAAD
CO-DIRECTOR
Tina S. Alster, MD, FAAD
SPEAKERS
Boncheol Goo
Robyn D. Siperstein, MD, FAAD
Rungsima Wanitphakdeedecha, MD, IFAAD
DISCLOSURES
Tina S. Alster, MD, FAAD
A Method – Consultant(Other Financial Benefit); Hair Sanity – Stockholder(Stock); PhyNet Dermatology – Employee (w-2 relationship)(Salary);
Boncheol Goo
Agnes Medical – Board of Directors(Patent royalties or other compensation for Intellectual Property Rights); Classys – Advisory Board(Honoraria); Colgate-Palmolive – Advisory Board(Honoraria); Pharmaresearch – Advisory Board(Honoraria); Speclipse – Board of Directors(Stock Options);
Monica Ka Yi Li, MD, FAAD
Amore Pacific – Speaker(Honoraria); Bausch Health – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Beiersdorf, Inc. – Consultant(Honoraria), Speaker(Honoraria); Candela Corporation – Consultant(Honoraria), Other(Equipment), Speaker(Honoraria); Cipher Pharmaceuticals – Speaker(Honoraria); Endo Pharmaceuticals – Advisory Board(Honoraria); Galderma Canada, Inc – Speaker(Non-accredited CME Education Grant); Galderma Global – Advisory Board(Honoraria); Kenvue – Advisory Board(Honoraria), Other(No Compensation Received); L'Oreal USA Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Merz Aesthetics – Speaker(Honoraria); Pfizer Inc. – Consultant(Honoraria), Speaker(Honoraria); Pierre Fabre – Speaker(Honoraria); Procter & Gamble Company – Consultant(Honoraria); Searchlight Pharma – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);
Robyn D. Siperstein, MD, FAAD
Allergan – Consultant (1099 relationship)(Fees); Allergan, Inc – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Galderma USA – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Sciton Inc. – Speaker(Fees), Stockholder Private Company(Stock);
Rungsima Wanitphakdeedecha, MD, IFAAD
No financial relationships exist with ineligible companies.